1Radford J, Pest E, Weisdorf D. Cytokine-stimulated engraftment syndrome (ES) after high dose chemotherapy (HI)C) with bone marrow (BM) and G-CSF-primed peripheral stem cell (GPSC)rescue. Blood, 1994, 84 (Suppl 1): 490. 被引量:1
2Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantaion. Bone Marrow Transplant, 2001, 27 : 893-898. 被引量:1
3Takatsuka H, Takemoto Y, Yamada S, et al. Complications after bone marrow transplantation are manifestation of systemic inflammatory response syndrome . Bone Marrow Transplant,2000, 26 : 419-426. 被引量:1
4Huber A, Kunkel SL, Todd RF, et al. Regulation of transendothelial neutrophil migration by endogenous interleukin 8. Science, 1991, 254 : 99-102. 被引量:1
5Ravoet C, Feremans W, Husson B, et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant, 1996, 18 : 943-947. 被引量:1
6Edenfield W J, Moores LK, Goodwin G, et al. An engraftment syndrome in autologous stem cell transplantaion related to mononuclear cell dose. Bone Marrow Transplant, 2000, 25:405-409. 被引量:1
7Kawano C, Muroi K, Kuribara R, et al. Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration. Bone Marrow Transplant, 2000, 25:228-229. 被引量:1
8Sato Y, Goto Y, Sato S, et al . Continuous subcutaneous injection reduces polymorphonuclear leukocyte activation by granulocyte colony-stimulating factor. Blood, 2004, 286 : 143-148. 被引量:1
9Nash RA, Bowen JD, McSweeney PA, et al. High-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation for multiple sclerosis. Blood, 2003, 102 : 2364-2372. 被引量:1
1Spitzer T R. Engraftment syndrome following hematopoietic stem cell transplantion. Bone Marrow Transplantion,2001,27:893--898. 被引量:1
2Lee C,Gingrich R D, Hohl R J,et al. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantion. Bone Marrow Transplantion, 1995,16:175--182. 被引量:1
3Kawano C, Muroi K, Kuribara R, et al. Engraftment syndrome after autologous peripheral blood stem cell transplantion with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration. Bone Marrow Transplantion,2000,25:228--229. 被引量:1
4Khan S, Gaa R, Hutcheson C, et al. Engraftment syndrome in breast cancer patients after BM/ peripheral blood stem cell transplant is associated with poor long-term survival. Blood, 2000,96 :332. 被引量:1
5Powles R, Morgenstern G, Kay H, et al. Mismatched family donors for bone-marrow transplantion as treatment for acute leukemia. Lancet, 1983,19 : 612 -- 615. 被引量:1
6Nurnberger W,Willers R,Burdach S,et al. Risk factors for capillary leakage syndrome after bone marrow transplantion . Ann Hematol, 1997,74 : 221 -- 224. 被引量:1
7Sykes M,Preffer F, Saidman S L, et al. Mixed lymphohematopoietic chimerism is achievable following nonmyeloablative therapy and HLA-mismatched donor marrow transplantion. Lancet, 1998,353 : 1755 -- 1759. 被引量:1
8Spitzer T, Mcafee S, Sackstein R, et al. Haploidentical donor bone marrow transplantation for advanced hematologic malignancy following non-myeloablative preparative therapy., role of in vivo T cell depletion with antithymocyte globulin or anti-CD2 monoclonal antibody therapy. Blood, 2000,96 : 841. 被引量:1
9Colby C, McAfee S, Sackstein R, et al. Engraftment syndrome following non-myeloablative condition therapy and HLA-matched bone marrow transplantation for hematologic malignancy. Blood, 2000,96 : 520. 被引量:1
10Raptis A, Mavroudis D, Suffredini A, et al. High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogenic bone marrow transplant recipients. Bone Marrow Transplantion, 1999,24:879-- 883. 被引量:1